Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea

BACKGROUND: We assessed the glucose-lowering efficacy of adding empagliflozin versus dose escalating existing medications in patients with uncontrolled type 2 diabetes (T2D). METHODS: This was a 6-month retrospective case-control study in subjects with uncontrolled T2D (glycated hemoglobin [HbA1c] &...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Yujin, Moon, Ji Hye, Chin, Ho Jun, Ferrannini, Ele, Lim, Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Endocrine Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386128/
https://www.ncbi.nlm.nih.gov/pubmed/32615717
http://dx.doi.org/10.3803/EnM.2020.35.2.329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386128/
https://www.ncbi.nlm.nih.gov/pubmed/32615717
http://dx.doi.org/10.3803/EnM.2020.35.2.329

Ejemplares similares